Clinical Trials

The purpose of this study is to determine if the fluid that collects in your retina, known as macular edema, changes throughout the course of a single day. If it does, this may change how the disease is treated in the future.

The purpose of this study is to explore the safety and effectiveness of REGN2176-3 on visual acuity in patients with neovascular age-related macular degeneration compared to using intravitreal aflibercept injection monotherapy.

The purposes of this study are to find out whether danicopan can slow the rate of geographic atrophy (GA) disease progression and slow the loss of visual function, to see how safe danicopan is for patients with GA by monitoring for any side effects, to see how the body responds to treatment with danicopan, to measure the levels of danicopan in blood over time, to find a safe and effective dose in patients with GA and how the body deals with the study drug at different dose levels, and to see the effect of danicopan on health-related quality of ...

The purpose of this study is to assess the safety and effectivness of abicipar pegol in patients with neovascular age-related macular degeneration.

The purpose of this study is to determine if macular degeneration patients have a shift in their circadian rhythm due to pathology within the macula compared to patients without macular pathology.